High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC …
R Willemze, S Suciu, G Meloni, B Labar… - Journal of clinical …, 2014 - ascopubs.org
Purpose Cytarabine plays a pivotal role in the treatment of patients with acute myeloid
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the …
R Willemze, S Suciu, G Meloni… - Journal of …, 2014 - scholarlypublications …
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger
Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 …
Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 …
High-Dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: Results of the EORTC …
R Willemze, S Suciu, GR Meloni, B Labar… - JOURNAL OF …, 2014 - iris.unito.it
Purpose Cytarabine plays a pivotal role in the treatment of patients with acute myeloid
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the …
R Willemze, S Suciu, G Meloni, B Labar… - Journal of clinical …, 2014 - publicatt.unicatt.it
Cytarabine plays a pivotal role in the treatment of patients with acute myeloid leukemia
(AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 mg/m (2) for …
(AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 mg/m (2) for …
[引用][C] High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the …
P Leoni - JOURNAL OF CLINICAL ONCOLOGY, 2014 - iris.univpm.it
High-dose cytarabine in induction treatment improves the outcome of adult patients younger
than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 …
than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 …
[引用][C] High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the …
R Willemze, S Suciu, G Meloni, B Labar… - JOURNAL OF …, 2014 - ricerca.uniba.it
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC …
R Willemze, S Suciu, G Meloni, B Labar… - JOURNAL OF …, 2014 - iris.unimore.it
Cytarabine plays a pivotal role in the treatment of patients with acute myeloid leukemia
(AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 mg/m (2) for …
(AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 mg/m (2) for …
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC …
R Willemze, S Suciu, G Meloni, B Labar, JP Marie… - 2014 - pubmed.ncbi.nlm.nih.gov
Purpose Cytarabine plays a pivotal role in the treatment of patients with acute myeloid
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
[引用][C] High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the …
R Willemze, S Suciu, G Meloni, B Labar, JP Marie… - 2014 - repository.ubn.ru.nl
PURPOSE: Cytarabine plays a pivotal role in the treatment of patients with acute myeloid
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the …
R Willemze, S Suciu, G Meloni, B Labar… - JOURNAL OF …, 2014 - avesis.ankara.edu.tr
Purpose Cytarabine plays a pivotal role in the treatment of patients with acute myeloid
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …
leukemia (AML). Most centers use 7 to 10 days of cytarabine at a daily dose of 100 to 200 …